{"gene":"COX17","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1996,"finding":"COX17 encodes a cytoplasmic cysteine-rich protein required for a late post-translational step in cytochrome c oxidase assembly; a cox17 null mutant is rescued by copper supplementation, establishing a specific role in delivering copper to mitochondria rather than general copper metabolism.","method":"Genetic complementation, null mutant rescue with copper supplementation, subunit expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational genetic and biochemical characterization replicated across multiple subsequent studies","pmids":["8662933"],"is_preprint":false},{"year":1998,"finding":"Yeast Cox17 binds copper as a binuclear cuprous-thiolate cluster with trigonally coordinated Cu(I) ions (three Cu-S bonds at 2.26 Å, Cu-Cu distance of 2.7 Å); the cluster is more labile than metallothionein clusters, consistent with a copper-delivery chaperone function.","method":"X-ray absorption spectroscopy (EXAFS), UV-visible absorption and emission spectroscopy","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro spectroscopic characterization of metal coordination, replicated and extended in subsequent structural studies","pmids":["9585572"],"is_preprint":false},{"year":2000,"finding":"Mutational analysis of yeast Cox17 identified three cysteines in a Cys-Cys-Xaa-Cys motif (residues 23, 24, 26) as critical for function; single Cys→Ser substitutions abolish cytochrome oxidase activity and respiratory growth without preventing Cu(I) binding or mitochondrial import, whereas the C57Y mutant fails to accumulate in mitochondria.","method":"Site-directed mutagenesis, respiratory growth assays, cytochrome oxidase activity measurement, Cu(I) binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with multiple functional and biochemical readouts in a single rigorous study","pmids":["10970896"],"is_preprint":false},{"year":2001,"finding":"Cox17 purified without a tag binds three Cu(I) ions per monomer in a polycopper cluster and exists in a dimer/tetramer equilibrium (Kd ~20 µM); Cys23, Cys24, or Cys26 substitutions abolish tetramerization and function without preventing Cu(I) binding, implicating oligomeric state in physiological function. Mitochondrial Cox17 is predominantly tetrameric; cytosolic Cox17 is primarily dimeric.","method":"X-ray absorption spectroscopy, analytical ultracentrifugation, site-directed mutagenesis, subcellular fractionation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods with mutagenesis in a single study","pmids":["11170391"],"is_preprint":false},{"year":2003,"finding":"Cox17 tethered to the mitochondrial inner membrane via a Sco2 transmembrane fusion fully rescues cox17Δ cells for respiratory growth and cytochrome oxidase activity, demonstrating that Cox17 function is confined to the mitochondrial intermembrane space. A C-terminal amphipathic helix is required for mitochondrial retention and is spatially separable from the N-terminal copper-binding domain.","method":"Mitochondrial membrane tethering fusion protein, respiratory growth complementation, cytochrome oxidase activity assay, domain mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic complementation with defined fusion construct plus domain mapping, single lab with multiple readouts","pmids":["14615477"],"is_preprint":false},{"year":2004,"finding":"Cox17 directly transfers Cu(I) to both Sco1 and Cox11 in vitro with high specificity (no transfer to BSA or carbonic anhydrase); a C57Y Cox17 mutant can transfer copper to Cox11 but not to Sco1, distinguishing the two transfer pathways. Transfer was corroborated by a yeast cytoplasmic co-expression system.","method":"In vitro copper transfer assay with purified proteins, yeast cytoplasm co-expression system, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro transfer with purified proteins, mutant dissection, and orthogonal in vivo validation","pmids":["15199057"],"is_preprint":false},{"year":2004,"finding":"NMR solution structure of yeast apo-Cox17 reveals two α-helices preceded by an intrinsically disordered N-terminal region; Cu(I) is coordinated by Cys23 and Cys26 in a two-coordinate site similar to Atx1-family chaperones, and Cu(I) binding orders the copper-binding region. ITC shows fully reduced Cox17 binds one Cu(I) with Ka ~6×10⁶ M⁻¹.","method":"NMR solution structure determination, isothermal titration calorimetry (ITC)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with ITC quantification of binding, single lab but multiple orthogonal methods","pmids":["15465825"],"is_preprint":false},{"year":2004,"finding":"Cox23p, a Cox17 homolog, is required for cytochrome oxidase assembly and operates upstream of Cox17 in the same pathway; Cox23p and Cox17p are not part of a stable complex with each other, and both localize to the mitochondrial intermembrane space and cytosol.","method":"Genetic epistasis (null mutant rescue by copper supplementation requires high-copy COX17), subcellular fractionation, co-immunoprecipitation (excluded complex)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by genetic rescue hierarchy with two orthogonal readouts, single lab","pmids":["15145942"],"is_preprint":false},{"year":2004,"finding":"Porcine Cox17 binds cooperatively four Cu⁺ ions forming a Cu₄S₆-type cluster; it also binds non-cooperatively two Zn²⁺ ions but not Ag⁺, demonstrating high metal-binding specificity. Partially oxidized Cox17 (two disulfide bonds) binds one Cu⁺ or Zn²⁺; fully oxidized Cox17 (three disulfide bonds) binds no metals.","method":"Electrospray ionization mass spectrometry (ESI-MS), fluorescence spectroscopy, DTT competition assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro quantitative metal-binding characterization with multiple spectroscopic methods in a single study","pmids":["15142040"],"is_preprint":false},{"year":2005,"finding":"NMR solution structure of oxidized apoCox17 reveals a coiled-coil fold stabilized by two disulfide bonds (Cys26/Cys57 and Cys36/Cys47); isomerization of the Cys26/Cys57 disulfide to Cys24/Cys57 is required prior to Cu(I) binding. A third fully oxidized form cannot bind copper; fully reduced Cox17 forms a molten globule that can bind up to four Cu(I) ions in a polycopper cluster and is oligomeric.","method":"NMR solution structure, disulfide bond analysis, Cu(I) binding assays","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure determination combined with biochemical characterization of multiple redox/metal states, replicated across labs","pmids":["15893662"],"is_preprint":false},{"year":2006,"finding":"The P174L mutation in human Sco1 severely compromises Cox17-dependent copper transfer to Sco1 in vitro and in a yeast cytoplasmic assay, but retains normal Cu(I) and Cu(II) binding; failure of Cox17-mediated metallation of Sco1 leads to rapid turnover of CoxII and COX assembly defects in patient fibroblasts.","method":"In vitro copper transfer assay, yeast cytoplasmic assay, pulse-chase labeling, patient fibroblast analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution, yeast genetic validation, and patient cell biochemistry in one study","pmids":["16520371"],"is_preprint":false},{"year":2007,"finding":"NMR solution structure of human Cox17 (Cox17²ˢ⁻ˢ) reveals a coiled-coil-helix-coiled-coil-helix domain stabilized by disulfides Cys25-Cys54 and Cys35-Cys44, with an unstructured N-terminal tail; Cu(I) is coordinated by Cys22 and Cys23 (Cys-Cys motif, first example in copper proteins). Redox measurements support that unstructured fully reduced Cox17 enters the IMS where Mia40-mediated oxidation to Cox17²ˢ⁻ˢ traps it and enables copper binding.","method":"NMR solution structure, redox potential measurements, subcellular localization analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with redox characterization; novel Cys-Cys copper coordination motif established","pmids":["18093982"],"is_preprint":false},{"year":2007,"finding":"Mammalian Cox17 exists in three oxidative states with distinct metal-binding properties: Cox17⁰ˢ⁻ˢ (fully reduced) binds four Cu⁺ cooperatively; Cox17²ˢ⁻ˢ (two disulfides) binds one Cu⁺ or Zn²⁺; Cox17³ˢ⁻ˢ (three disulfides) binds no metals. Redox midpoint potentials: Em1 = -197 mV (Cox17³ˢ⁻ˢ↔Cox17²ˢ⁻ˢ), Em2 = -340 mV (Cox17²ˢ⁻ˢ↔Cox17⁰ˢ⁻ˢ). XAS confirms a Cu₄S₆-type cluster in Cu₄Cox17.","method":"Redox potential determination, X-ray absorption spectroscopy (XAS), ESI-MS","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods (XAS, electrochemistry, MS) in a single study","pmids":["17672825"],"is_preprint":false},{"year":2008,"finding":"Human Cox17²ˢ⁻ˢ loaded with Cu(I) transfers copper and two electrons simultaneously to oxidized HSco1 (disulfide form), yielding Cu(I)HSco1 and fully oxidized apoHCox17³ˢ⁻ˢ; glutathione can reduce apoHCox17³ˢ⁻ˢ back to Cox17²ˢ⁻ˢ. This coupled copper-electron transfer does not occur with HSco2 due to lack of a specific metal-bridged protein-protein complex.","method":"In vitro copper transfer assay with purified proteins, NMR spectroscopy to detect protein-protein complex, redox analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro coupled copper/electron transfer with NMR detection of intermediate complex; mechanistically novel finding","pmids":["18458339"],"is_preprint":false},{"year":2009,"finding":"COX17 siRNA knockdown in HeLa cells reduces cytochrome c oxidase activity and assembly; COX-containing respiratory supercomplexes disappear as an early response, and a novel ~150 kDa complex accumulates containing Cox1 but not Cox2, suggesting Cox17 absence specifically impairs copper delivery to Cox2.","method":"siRNA knockdown, blue native gel electrophoresis, cytochrome c oxidase activity assay","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with defined biochemical phenotype and intermediate complex identification, single lab","pmids":["19393246"],"is_preprint":false},{"year":2011,"finding":"Structural analysis of human Cox17 mutants with single disulfide bonds shows the inner disulfide (Cys36-Cys45) stabilizes interhelical hydrophobic interactions and is sufficient to maintain the mature Cox17 structure/dynamics, while the external disulfide (Cys26-Cys55) organizes the copper-binding site region but cannot stabilize interhelical packing.","method":"NMR structure determination and backbone mobility analysis of Cox17 disulfide mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural analysis with functional mutants defining individual disulfide roles","pmids":["21816817"],"is_preprint":false},{"year":2015,"finding":"Cox17 directly interacts with Mic60 of the MICOS complex, modulating MICOS integrity and inner mitochondrial membrane architecture; this interaction is independent of Sco1 but is regulated by copper ions.","method":"Co-immunoprecipitation, genetic interaction analysis, MICOS complex integrity assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP with functional consequence on MICOS integrity shown, single lab","pmids":["25918166"],"is_preprint":false},{"year":2015,"finding":"Cox17 facilitates delivery of cisplatin to mitochondria; glutathione significantly modulates platinum binding to Cox17, with cisplatin-GSH adducts transferring >90% platinum to Cox17, while transplatin-GSH adducts are inert to Cox17, and GSH attenuates Cox17 aggregation induced by platination.","method":"Kinetic binding assays, platinum transfer assays, protein aggregation assays","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro reconstitution of platinum transfer, single lab, single study","pmids":["26399480"],"is_preprint":false},{"year":2016,"finding":"Cisplatin binds to human Cox17²ˢ⁻ˢ primarily at Cys26 or Cys27 (the Cu(I)-binding site), as determined by top-down FT-ICR-MS/MS with electron capture dissociation, demonstrating competitive coordination with cuprous ions.","method":"High-resolution FT-ICR tandem mass spectrometry with electron capture dissociation (ECD)","journal":"Rapid communications in mass spectrometry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct site identification by top-down MS, single lab, single method","pmids":["27539433"],"is_preprint":false},{"year":2019,"finding":"Stable COX17 shRNA knockdown in HEK293 cells causes decreased intramitochondrial copper content, reduced levels of COX subunits (Cox1, Cox4, Cox5a), accumulation of COX subcomplexes, and mitochondrial ultrastructural changes including cristae reduction and mitochondrial swelling, confirming copper chaperone role in human cells.","method":"Stable shRNA knockdown, copper quantification, BN-PAGE, electron microscopy, western blot","journal":"Folia biologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with multiple biochemical and ultrastructural readouts, single lab","pmids":["31903891"],"is_preprint":false},{"year":2023,"finding":"COX17 is acetylated by the MOF-KANSL lysine acetyltransferase complex; loss of MOF or COX17, or expression of non-acetylatable COX17 mutant, causes mitochondrial fragmentation, reduced cristae density, and impaired complex IV integrity; acetylation-mimetic COX17 rescues complex IV activity even in absence of MOF, establishing activatory role of COX17 acetylation.","method":"MOF knockout/knockdown, site-directed mutagenesis (acetylation-mimetic and non-acetylatable mutants), mitochondrial complex IV activity assay, electron microscopy, patient fibroblast complementation","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (KO, mutagenesis, patient cells, rescue), identification of writer (MOF), functional consequence established","pmids":["37813994"],"is_preprint":false},{"year":2023,"finding":"Lead (Pb) exposure enhances mitochondrial translocation of COX17 via the AIF/CHCHD4 mitochondrial import pathway, increasing mitochondrial copper concentration and causing mitochondrial damage in microglia; copper-chelating agents or inhibition of COX17 mitochondrial translocation reverses this effect.","method":"In vivo APP/PS1 mouse model, in vitro BV-2 cell model, copper quantification, mitochondrial fractionation, pathway inhibition","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro models with mechanistic rescue, single lab","pmids":["38091880"],"is_preprint":false},{"year":2023,"finding":"COX17 knockdown in fibrotic kidney models aggravates mitochondrial copper accumulation and inhibits complex IV activity, while COX17 overexpression discharges excess mitochondrial copper and restores complex IV function, demonstrating a bidirectional role of COX17 in mitochondrial copper homeostasis and complex IV maintenance.","method":"UUO mouse model, TGF-β1 in vitro fibrosis model, COX17 knockdown and overexpression, complex activity assays, copper quantification","journal":"Acta pharmacologica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro bidirectional manipulation with defined biochemical readouts, single lab","pmids":["37217601"],"is_preprint":false},{"year":1997,"finding":"A human cDNA encoding a protein homologous to yeast Cox17p functionally complements a yeast cox17 null mutant for respiratory growth, establishing functional conservation of the copper-delivery mechanism in human cells.","method":"Functional complementation of yeast cox17 null mutant with human cDNA expression library","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct functional complementation across species, replicated in subsequent studies","pmids":["9050918"],"is_preprint":false}],"current_model":"COX17 is a mitochondrial intermembrane space copper chaperone that, in its partially oxidized form (two disulfide bonds, Cox17²ˢ⁻ˢ), binds one Cu(I) ion via a Cys-Cys motif and directly transfers copper—coupled to electron transfer—to both Sco1 (for the Cu_A site of Cox2) and Cox11 (for the Cu_B site of Cox1) during cytochrome c oxidase assembly; it is imported into the IMS in its unstructured reduced form and trapped there by Mia40-dependent disulfide oxidation, its activity is positively regulated by MOF-mediated acetylation, it interacts with the MICOS component Mic60 to modulate inner membrane architecture in a copper-regulated manner, and it also facilitates cisplatin delivery to mitochondria by binding the drug at its Cu(I)-coordination cysteines."},"narrative":{"mechanistic_narrative":"COX17 is a mitochondrial intermembrane space (IMS) copper chaperone that delivers copper to the cytochrome c oxidase (complex IV) assembly machinery, a role first established genetically when a cox17 null mutant was shown to be specifically rescued by copper supplementation [PMID:8662933] and confirmed to be functionally conserved in humans by complementation of the yeast mutant [PMID:9050918]. The protein is imported into the IMS in an unstructured, fully reduced state and trapped there by Mia40-dependent oxidation to the Cox17²ˢ⁻ˢ form, which acquires a coiled-coil-helix fold stabilized by two disulfide bonds and binds a single Cu(I) ion through a Cys-Cys motif [PMID:18093982, PMID:15893662]. Its redox-dependent metal-binding repertoire is graded across oxidation states: fully reduced Cox17 binds up to four Cu(I) ions in a polycopper Cu₄S₆ cluster, the doubly-disulfide form binds one Cu(I), and the fully oxidized form binds none [PMID:17672825, PMID:15142040, PMID:15893662]. A C-terminal amphipathic helix retains Cox17 in the IMS, and tethering it to the inner membrane fully restores function, demonstrating that its activity is confined to this compartment [PMID:14615477]. The metallated Cox17²ˢ⁻ˢ form directly and specifically transfers Cu(I) to both Sco1 and Cox11 in vitro, feeding the Cu_A and Cu_B sites of complex IV; transfer to Sco1 is mechanistically coupled to a two-electron transfer that oxidizes Cox17 to its disulfide form, and the C57Y mutant selectively loses the Sco1 pathway while retaining transfer to Cox11 [PMID:15199057, PMID:18458339]. Disruption of COX17 in human cells reduces intramitochondrial copper, impairs complex IV assembly with accumulation of subassemblies lacking copper-loaded Cox2, and alters mitochondrial cristae ultrastructure [PMID:19393246, PMID:31903891]. The chaperone's activity is positively regulated by MOF-KANSL-mediated acetylation [PMID:37813994], and it interacts with the MICOS component Mic60 to modulate inner-membrane architecture in a copper-regulated manner [PMID:25918166]. A patient SCO1 P174L mutation that blocks Cox17-mediated metallation of Sco1 establishes the clinical relevance of this transfer step to complex IV deficiency [PMID:16520371]. Beyond copper handling, Cox17 binds cisplatin at its Cu(I)-coordinating cysteines and facilitates platinum delivery to mitochondria [PMID:27539433, PMID:26399480].","teleology":[{"year":1996,"claim":"Established that COX17 is dedicated to copper delivery for complex IV assembly rather than general copper metabolism, defining the gene's biological purpose.","evidence":"Genetic complementation and copper-supplementation rescue of a yeast cox17 null mutant","pmids":["8662933"],"confidence":"High","gaps":["Did not localize the protein or identify the molecular form of copper delivered","Downstream acceptors of copper not yet identified"]},{"year":1997,"claim":"Showed the copper-delivery mechanism is conserved to humans, validating yeast as a model for the human chaperone.","evidence":"Functional complementation of yeast cox17 null with human cDNA","pmids":["9050918"],"confidence":"High","gaps":["Did not characterize human protein structure or partners","Conservation of mechanism inferred from rescue, not directly demonstrated biochemically"]},{"year":1998,"claim":"Defined the chemical nature of copper binding, distinguishing a labile delivery-competent cluster from stable storage proteins.","evidence":"EXAFS and UV-vis/emission spectroscopy of the cuprous-thiolate cluster","pmids":["9585572"],"confidence":"High","gaps":["Did not assign individual coordinating cysteines","Physiological oxidation state and oligomeric form unresolved"]},{"year":2000,"claim":"Identified the Cys-Cys-Xaa-Cys motif as functionally essential and separated the requirement for copper binding from in vivo function, indicating function depends on more than metal coordination alone.","evidence":"Site-directed mutagenesis with respiratory growth, COX activity, Cu(I) binding, and import readouts in yeast","pmids":["10970896"],"confidence":"High","gaps":["Why Cys mutants that still bind copper are non-functional was unexplained","Did not define the role of disulfides versus thiols"]},{"year":2001,"claim":"Linked oligomeric state to function, showing tetramerization correlates with mitochondrial localization and physiological activity.","evidence":"XAS, analytical ultracentrifugation, mutagenesis, and subcellular fractionation of yeast Cox17","pmids":["11170391"],"confidence":"High","gaps":["Functional necessity of tetramer for copper transfer not directly tested","Relationship between oligomerization and redox state unclear"]},{"year":2003,"claim":"Resolved the long-standing question of where Cox17 acts by confining its function to the IMS and mapping a separable membrane-retention helix.","evidence":"Inner-membrane tethering fusion with respiratory complementation and domain mapping in yeast","pmids":["14615477"],"confidence":"High","gaps":["Did not address the reported cytosolic pool's function","Mechanism of IMS retention by the amphipathic helix not detailed"]},{"year":2004,"claim":"Demonstrated Cox17 directly and specifically metallates both Sco1 and Cox11, defining the two downstream copper acceptors and revealing genetically separable transfer pathways.","evidence":"In vitro Cu(I) transfer with purified proteins, C57Y mutant dissection, and yeast cytoplasmic co-expression","pmids":["15199057"],"confidence":"High","gaps":["Did not resolve why C57Y selectively loses the Sco1 route","Stoichiometry and complex intermediates of transfer not defined here"]},{"year":2004,"claim":"Placed Cox23 upstream of Cox17 in the same assembly pathway, hinting at a multi-step copper relay without a stable Cox17-Cox23 complex.","evidence":"Genetic epistasis by high-copy COX17 rescue, fractionation, and exclusion Co-IP in yeast","pmids":["15145942"],"confidence":"Medium","gaps":["The biochemical activity of Cox23 and the nature of its handoff to Cox17 unknown","Transient interaction not excluded"]},{"year":2004,"claim":"Quantified the redox-state-dependent metal-binding hierarchy, showing oxidation tunes copper capacity from four ions to one to none.","evidence":"ESI-MS, fluorescence, and DTT competition on porcine Cox17","pmids":["15142040"],"confidence":"High","gaps":["Physiologically active oxidation state in vivo not pinned down","Functional role of Zn(II) binding unclear"]},{"year":2004,"claim":"Provided the first apo-structure showing an intrinsically disordered N-terminus that becomes ordered on Cu(I) binding via a two-coordinate Atx1-like site.","evidence":"NMR solution structure and ITC of yeast apo-Cox17","pmids":["15465825"],"confidence":"High","gaps":["Structure of the metallated transfer-competent state not solved here","Disulfide topology not yet integrated"]},{"year":2005,"claim":"Defined the disulfide-folded oxidized structure and a required disulfide isomerization step preceding copper binding, framing oxidation as the maturation switch.","evidence":"NMR structures of oxidized apoCox17 and biochemical analysis of redox/metal states","pmids":["15893662"],"confidence":"High","gaps":["The catalyst of the required disulfide isomerization not identified here","Coupling of isomerization to import not yet shown"]},{"year":2006,"claim":"Connected Cox17-dependent Sco1 metallation to human disease by showing a patient SCO1 mutation blocks copper transfer without disrupting Sco1 metal binding.","evidence":"In vitro and yeast transfer assays, pulse-chase, and patient fibroblast analysis of SCO1 P174L","pmids":["16520371"],"confidence":"High","gaps":["The structural basis of the transfer-specific defect not resolved","Whether COX17 mutations themselves cause disease not addressed"]},{"year":2007,"claim":"Established the human Cox17²ˢ⁻ˢ structure with the novel Cys-Cys copper coordination motif and linked Mia40-mediated oxidation to IMS trapping and copper-binding competence.","evidence":"NMR solution structure, redox potential measurement, and localization of human Cox17","pmids":["18093982"],"confidence":"High","gaps":["Direct demonstration of Mia40 oxidation of Cox17 in vivo not shown here","Kinetics of import-coupled folding undefined"]},{"year":2007,"claim":"Measured redox midpoint potentials defining the energetics that govern interconversion among the three oxidation states and their distinct copper capacities.","evidence":"Electrochemical redox titration, XAS, and ESI-MS on mammalian Cox17","pmids":["17672825"],"confidence":"High","gaps":["In vivo redox poise of the IMS Cox17 pool not determined","Coupling of potentials to physiological redox partners not tested"]},{"year":2008,"claim":"Revealed that copper transfer to Sco1 is mechanistically coupled to a two-electron transfer through a metal-bridged complex, explaining the Sco1/Sco2 transfer specificity.","evidence":"In vitro coupled copper/electron transfer with NMR detection of the intermediate complex and redox analysis","pmids":["18458339"],"confidence":"High","gaps":["Structural model of the transient Cox17-Sco1 complex not resolved","Source of reducing equivalents (GSH) regulation in vivo unquantified"]},{"year":2009,"claim":"Demonstrated in human cells that loss of Cox17 specifically blocks copper delivery to Cox2, with loss of supercomplexes and accumulation of a Cox1-containing, Cox2-deficient intermediate.","evidence":"siRNA knockdown, BN-PAGE, and COX activity assay in HeLa cells","pmids":["19393246"],"confidence":"Medium","gaps":["Direct linkage of the 150 kDa intermediate to copper status not biochemically proven","Effects on Cox1 Cu_B metallation not separately assessed"]},{"year":2011,"claim":"Dissected the distinct structural roles of the two disulfides, separating interhelical stabilization from copper-site organization.","evidence":"NMR structure and backbone dynamics of single-disulfide human Cox17 mutants","pmids":["21816817"],"confidence":"High","gaps":["Functional copper-transfer competence of single-disulfide forms not tested","In vivo abundance of these intermediate forms unknown"]},{"year":2015,"claim":"Extended Cox17 function beyond copper relay by showing a copper-regulated interaction with Mic60 that modulates MICOS integrity and inner-membrane architecture.","evidence":"Co-IP, genetic interaction, and MICOS integrity assays","pmids":["25918166"],"confidence":"Medium","gaps":["Single-lab Co-IP without structural mapping of the interface","Whether this is a moonlighting role or coupled to copper delivery unclear"]},{"year":2015,"claim":"Identified Cox17 as a facilitator of cisplatin delivery to mitochondria, with glutathione gating platinum loading.","evidence":"Kinetic binding, platinum transfer, and aggregation assays in vitro","pmids":["26399480"],"confidence":"Medium","gaps":["In vivo relevance to cisplatin pharmacology not established","Single in vitro study"]},{"year":2016,"claim":"Localized cisplatin binding to the Cu(I)-coordinating cysteines, defining competitive metal/drug coordination at the chaperone's active site.","evidence":"Top-down FT-ICR MS/MS with electron capture dissociation","pmids":["27539433"],"confidence":"Medium","gaps":["Single-method site assignment without orthogonal confirmation","Functional consequence for copper chaperone activity not measured"]},{"year":2019,"claim":"Confirmed the human copper-chaperone role with a clean phenotype linking COX17 loss to reduced mitochondrial copper, COX subassembly accumulation, and cristae defects.","evidence":"Stable shRNA knockdown, copper quantification, BN-PAGE, EM, and western blot in HEK293 cells","pmids":["31903891"],"confidence":"Medium","gaps":["Single-lab study","Did not distinguish direct copper-delivery defect from secondary mitochondrial damage"]},{"year":2023,"claim":"Identified MOF-KANSL acetylation as a positive regulatory input controlling Cox17 activity and complex IV integrity.","evidence":"MOF KO/KD, acetylation-mimetic and non-acetylatable mutants, complex IV assays, EM, and patient fibroblast rescue","pmids":["37813994"],"confidence":"High","gaps":["Acetylated residue's effect on copper binding/transfer mechanism not resolved","Deacetylase and physiological signals tuning acetylation unknown"]},{"year":2023,"claim":"Revealed inducible mitochondrial import of COX17 via the AIF/CHCHD4 pathway as a route by which lead exposure drives mitochondrial copper overload and damage.","evidence":"APP/PS1 mouse and BV-2 cell models, copper quantification, fractionation, and pathway inhibition","pmids":["38091880"],"confidence":"Medium","gaps":["Whether enhanced import reflects increased flux through normal machinery or a stress-specific route unclear","Single-lab study"]},{"year":2023,"claim":"Showed COX17 acts bidirectionally in mitochondrial copper homeostasis, both maintaining complex IV and discharging excess copper.","evidence":"UUO and TGF-β1 fibrosis models with COX17 knockdown and overexpression, activity assays, and copper quantification","pmids":["37217601"],"confidence":"Medium","gaps":["Molecular basis of copper efflux/discharge function not defined","Single-lab study"]},{"year":null,"claim":"How the multiple Cox17 functions—copper relay, MICOS modulation, acetylation control, and copper efflux—are integrated and prioritized in vivo, and whether COX17 variants directly cause human complex IV disease, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the transfer-competent Cox17-Sco1/Cox11 complexes in cells","No reported COX17 disease mutation despite established pathway relevance","Mechanism of copper discharge/efflux unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,5,13]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[1,8,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,13]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[4,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,7]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,14,19]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,19,22]}],"complexes":[],"partners":["SCO1","COX11","MIC60","MOF"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14061","full_name":"Cytochrome c oxidase copper chaperone","aliases":[],"length_aa":63,"mass_kda":6.9,"function":"Copper metallochaperone involved in the assembly of cytochrome c oxidase (respiratory chain complex IV, CIV) (PubMed:15229189, PubMed:19393246, PubMed:31903891, PubMed:35750769). Binds two copper ions and delivers them to metallochaperones SCO1 and SCO2, which co-chaperone the copper ions to the Cu(A) site on the cytochrome c oxidase subunit II (MT-CO2/COX2), and to metallochaperone COX11 which relays the copper to the Cu(B) site on the cytochrome c oxidase subunit I (MT-CO1/COX1) (PubMed:15229189, PubMed:19393246, PubMed:35750769)","subcellular_location":"Mitochondrion intermembrane space; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q14061/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/COX17","classification":"Common Essential","n_dependent_lines":1059,"n_total_lines":1208,"dependency_fraction":0.8766556291390728},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/COX17","total_profiled":1310},"omim":[{"mim_id":"614771","title":"PET117 CYTOCHROME c OXIDASE CHAPERONE; PET117","url":"https://www.omim.org/entry/614771"},{"mim_id":"614770","title":"PET100 CYTOCHROME c OXIDASE CHAPERONE; PET100","url":"https://www.omim.org/entry/614770"},{"mim_id":"614769","title":"CYTOCHROME c OXIDASE ASSEMBLY FACTOR 1; COA1","url":"https://www.omim.org/entry/614769"},{"mim_id":"610429","title":"CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX19; COX19","url":"https://www.omim.org/entry/610429"},{"mim_id":"604813","title":"CYTOCHROME c OXIDASE COPPER CHAPERONE COX17; COX17","url":"https://www.omim.org/entry/604813"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/COX17"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q14061","domains":[{"cath_id":"1.10.287","chopping":"26-58","consensus_level":"high","plddt":86.8621,"start":26,"end":58}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14061","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14061-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14061-F1-predicted_aligned_error_v6.png","plddt_mean":72.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COX17","jax_strain_url":"https://www.jax.org/strain/search?query=COX17"},"sequence":{"accession":"Q14061","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14061.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14061/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14061"}},"corpus_meta":[{"pmid":"8662933","id":"PMC_8662933","title":"Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662933","citation_count":396,"is_preprint":false},{"pmid":"15199057","id":"PMC_15199057","title":"Specific copper transfer from the Cox17 metallochaperone to both Sco1 and Cox11 in the assembly of yeast cytochrome C oxidase.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15199057","citation_count":244,"is_preprint":false},{"pmid":"18458339","id":"PMC_18458339","title":"Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupled to electron transfer.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18458339","citation_count":162,"is_preprint":false},{"pmid":"9050918","id":"PMC_9050918","title":"Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9050918","citation_count":126,"is_preprint":false},{"pmid":"11170391","id":"PMC_11170391","title":"The mitochondrial copper metallochaperone Cox17 exists as an oligomeric, polycopper complex.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11170391","citation_count":113,"is_preprint":false},{"pmid":"15893662","id":"PMC_15893662","title":"Folding studies of Cox17 reveal an important interplay of cysteine oxidation and copper binding.","date":"2005","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/15893662","citation_count":108,"is_preprint":false},{"pmid":"14615477","id":"PMC_14615477","title":"Cox17 is functional when tethered to the mitochondrial inner membrane.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14615477","citation_count":97,"is_preprint":false},{"pmid":"9585572","id":"PMC_9585572","title":"Characterization of the copper chaperone Cox17 of Saccharomyces cerevisiae.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9585572","citation_count":93,"is_preprint":false},{"pmid":"15465825","id":"PMC_15465825","title":"Yeast cox17 solution structure and Copper(I) binding.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15465825","citation_count":91,"is_preprint":false},{"pmid":"18093982","id":"PMC_18093982","title":"A structural-dynamical characterization of human Cox17.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18093982","citation_count":86,"is_preprint":false},{"pmid":"10970896","id":"PMC_10970896","title":"Mutational analysis of the mitochondrial copper metallochaperone Cox17.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10970896","citation_count":85,"is_preprint":false},{"pmid":"15142040","id":"PMC_15142040","title":"Metal-binding mechanism of Cox17, a copper chaperone for cytochrome c oxidase.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15142040","citation_count":81,"is_preprint":false},{"pmid":"15145942","id":"PMC_15145942","title":"COX23, a homologue of COX17, is required for cytochrome oxidase assembly.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15145942","citation_count":70,"is_preprint":false},{"pmid":"14612491","id":"PMC_14612491","title":"Identification of COX17 as a therapeutic target for non-small cell lung cancer.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14612491","citation_count":67,"is_preprint":false},{"pmid":"38091880","id":"PMC_38091880","title":"Lead aggravates Alzheimer's disease pathology via mitochondrial copper accumulation regulated by COX17.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38091880","citation_count":61,"is_preprint":false},{"pmid":"17672825","id":"PMC_17672825","title":"Oxidative switches in functioning of mammalian copper chaperone Cox17.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17672825","citation_count":51,"is_preprint":false},{"pmid":"19393246","id":"PMC_19393246","title":"Knockdown of human COX17 affects assembly and supramolecular organization of cytochrome c oxidase.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19393246","citation_count":49,"is_preprint":false},{"pmid":"37217601","id":"PMC_37217601","title":"COX17 restricts renal fibrosis development by maintaining mitochondrial copper homeostasis and restoring complex IV activity.","date":"2023","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/37217601","citation_count":45,"is_preprint":false},{"pmid":"25918166","id":"PMC_25918166","title":"Cox17 Protein Is an Auxiliary Factor Involved in the Control of the Mitochondrial Contact Site and Cristae Organizing System.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25918166","citation_count":41,"is_preprint":false},{"pmid":"10982038","id":"PMC_10982038","title":"Characterization and localization of human COX17, a gene involved in mitochondrial copper transport.","date":"2000","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10982038","citation_count":32,"is_preprint":false},{"pmid":"11027508","id":"PMC_11027508","title":"Characterization of human SCO1 and COX17 genes in mitochondrial cytochrome-c-oxidase deficiency.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11027508","citation_count":30,"is_preprint":false},{"pmid":"16520371","id":"PMC_16520371","title":"The P174L mutation in human Sco1 severely compromises Cox17-dependent metallation but does not impair copper binding.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16520371","citation_count":29,"is_preprint":false},{"pmid":"37813994","id":"PMC_37813994","title":"COX17 acetylation via MOF-KANSL complex promotes mitochondrial integrity and function.","date":"2023","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/37813994","citation_count":27,"is_preprint":false},{"pmid":"31903891","id":"PMC_31903891","title":"Stable COX17 Downregulation Leads to Alterations in Mitochondrial Ultrastructure, Decreased Copper Content and Impaired Cytochrome c Oxidase Biogenesis in HEK293 Cells.","date":"2019","source":"Folia biologica","url":"https://pubmed.ncbi.nlm.nih.gov/31903891","citation_count":22,"is_preprint":false},{"pmid":"11997103","id":"PMC_11997103","title":"Characterization and identification of promoter elements in the mouse COX17 gene.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11997103","citation_count":21,"is_preprint":false},{"pmid":"21816817","id":"PMC_21816817","title":"Functional role of two interhelical disulfide bonds in human Cox17 protein from a structural perspective.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21816817","citation_count":16,"is_preprint":false},{"pmid":"26399480","id":"PMC_26399480","title":"Glutathione selectively modulates the binding of platinum drugs to human copper chaperone Cox17.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26399480","citation_count":16,"is_preprint":false},{"pmid":"36208295","id":"PMC_36208295","title":"Zebrafish cox17 modulates primitive erythropoiesis via regulation of mitochondrial metabolism to facilitate hypoxia tolerance.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36208295","citation_count":15,"is_preprint":false},{"pmid":"17208454","id":"PMC_17208454","title":"Cox17, a copper chaperone for cytochrome c oxidase: expression, purification, and formation of mixed disulphide adducts with thiol reagents.","date":"2006","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/17208454","citation_count":14,"is_preprint":false},{"pmid":"31662245","id":"PMC_31662245","title":"Transcriptional profiles and copper stress responses in zebrafish cox17 mutants.","date":"2019","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/31662245","citation_count":11,"is_preprint":false},{"pmid":"30317392","id":"PMC_30317392","title":"The nonsense-mediated mRNA decay (NMD) pathway differentially regulates COX17, COX19 and COX23 mRNAs.","date":"2018","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30317392","citation_count":11,"is_preprint":false},{"pmid":"25447123","id":"PMC_25447123","title":"Identification and initial characterisation of a Plasmodium falciparum Cox17 copper metallochaperone.","date":"2014","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25447123","citation_count":11,"is_preprint":false},{"pmid":"27539433","id":"PMC_27539433","title":"Identification of binding sites of cisplatin to human copper chaperone protein Cox17 by high-resolution FT-ICR-MS.","date":"2016","source":"Rapid communications in mass spectrometry : RCM","url":"https://pubmed.ncbi.nlm.nih.gov/27539433","citation_count":7,"is_preprint":false},{"pmid":"19018666","id":"PMC_19018666","title":"Modulation of redox switches of copper chaperone Cox17 by Zn(II) ions determined by new ESI MS-based approach.","date":"2009","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19018666","citation_count":6,"is_preprint":false},{"pmid":"11913776","id":"PMC_11913776","title":"Genomic structure of mouse copper chaperone, COX17.","date":"2001","source":"DNA sequence : the journal of DNA sequencing and mapping","url":"https://pubmed.ncbi.nlm.nih.gov/11913776","citation_count":4,"is_preprint":false},{"pmid":"27235272","id":"PMC_27235272","title":"A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry.","date":"2016","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27235272","citation_count":2,"is_preprint":false},{"pmid":"40945651","id":"PMC_40945651","title":"Cisplatin transported by COX17 induces cochlear damage by binding Myosin IIA to regulate cell pyroptosis induced by mitochondrial dysfunction.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40945651","citation_count":1,"is_preprint":false},{"pmid":"41792107","id":"PMC_41792107","title":"Lysophosphatidylcholine acyltransferase 1 promotes head and neck squamous cell carcinoma progression by enhancing COX17-dependent oxidative phosphorylation.","date":"2026","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41792107","citation_count":0,"is_preprint":false},{"pmid":"41347662","id":"PMC_41347662","title":"COX17 Attenuates Diabetes-Associated Retinal Injury by Improving Mitochondrial Function.","date":"2026","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41347662","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.13.642976","title":"Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy","date":"2025-03-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.13.642976","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20220,"output_tokens":5769,"usd":0.073597,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14599,"output_tokens":6278,"usd":0.114973,"stage2_stop_reason":"end_turn"},"total_usd":0.18857,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"COX17 encodes a cytoplasmic cysteine-rich protein required for a late post-translational step in cytochrome c oxidase assembly; a cox17 null mutant is rescued by copper supplementation, establishing a specific role in delivering copper to mitochondria rather than general copper metabolism.\",\n      \"method\": \"Genetic complementation, null mutant rescue with copper supplementation, subunit expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational genetic and biochemical characterization replicated across multiple subsequent studies\",\n      \"pmids\": [\"8662933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Yeast Cox17 binds copper as a binuclear cuprous-thiolate cluster with trigonally coordinated Cu(I) ions (three Cu-S bonds at 2.26 Å, Cu-Cu distance of 2.7 Å); the cluster is more labile than metallothionein clusters, consistent with a copper-delivery chaperone function.\",\n      \"method\": \"X-ray absorption spectroscopy (EXAFS), UV-visible absorption and emission spectroscopy\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro spectroscopic characterization of metal coordination, replicated and extended in subsequent structural studies\",\n      \"pmids\": [\"9585572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Mutational analysis of yeast Cox17 identified three cysteines in a Cys-Cys-Xaa-Cys motif (residues 23, 24, 26) as critical for function; single Cys→Ser substitutions abolish cytochrome oxidase activity and respiratory growth without preventing Cu(I) binding or mitochondrial import, whereas the C57Y mutant fails to accumulate in mitochondria.\",\n      \"method\": \"Site-directed mutagenesis, respiratory growth assays, cytochrome oxidase activity measurement, Cu(I) binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with multiple functional and biochemical readouts in a single rigorous study\",\n      \"pmids\": [\"10970896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cox17 purified without a tag binds three Cu(I) ions per monomer in a polycopper cluster and exists in a dimer/tetramer equilibrium (Kd ~20 µM); Cys23, Cys24, or Cys26 substitutions abolish tetramerization and function without preventing Cu(I) binding, implicating oligomeric state in physiological function. Mitochondrial Cox17 is predominantly tetrameric; cytosolic Cox17 is primarily dimeric.\",\n      \"method\": \"X-ray absorption spectroscopy, analytical ultracentrifugation, site-directed mutagenesis, subcellular fractionation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods with mutagenesis in a single study\",\n      \"pmids\": [\"11170391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cox17 tethered to the mitochondrial inner membrane via a Sco2 transmembrane fusion fully rescues cox17Δ cells for respiratory growth and cytochrome oxidase activity, demonstrating that Cox17 function is confined to the mitochondrial intermembrane space. A C-terminal amphipathic helix is required for mitochondrial retention and is spatially separable from the N-terminal copper-binding domain.\",\n      \"method\": \"Mitochondrial membrane tethering fusion protein, respiratory growth complementation, cytochrome oxidase activity assay, domain mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic complementation with defined fusion construct plus domain mapping, single lab with multiple readouts\",\n      \"pmids\": [\"14615477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cox17 directly transfers Cu(I) to both Sco1 and Cox11 in vitro with high specificity (no transfer to BSA or carbonic anhydrase); a C57Y Cox17 mutant can transfer copper to Cox11 but not to Sco1, distinguishing the two transfer pathways. Transfer was corroborated by a yeast cytoplasmic co-expression system.\",\n      \"method\": \"In vitro copper transfer assay with purified proteins, yeast cytoplasm co-expression system, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro transfer with purified proteins, mutant dissection, and orthogonal in vivo validation\",\n      \"pmids\": [\"15199057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NMR solution structure of yeast apo-Cox17 reveals two α-helices preceded by an intrinsically disordered N-terminal region; Cu(I) is coordinated by Cys23 and Cys26 in a two-coordinate site similar to Atx1-family chaperones, and Cu(I) binding orders the copper-binding region. ITC shows fully reduced Cox17 binds one Cu(I) with Ka ~6×10⁶ M⁻¹.\",\n      \"method\": \"NMR solution structure determination, isothermal titration calorimetry (ITC)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with ITC quantification of binding, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"15465825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cox23p, a Cox17 homolog, is required for cytochrome oxidase assembly and operates upstream of Cox17 in the same pathway; Cox23p and Cox17p are not part of a stable complex with each other, and both localize to the mitochondrial intermembrane space and cytosol.\",\n      \"method\": \"Genetic epistasis (null mutant rescue by copper supplementation requires high-copy COX17), subcellular fractionation, co-immunoprecipitation (excluded complex)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by genetic rescue hierarchy with two orthogonal readouts, single lab\",\n      \"pmids\": [\"15145942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Porcine Cox17 binds cooperatively four Cu⁺ ions forming a Cu₄S₆-type cluster; it also binds non-cooperatively two Zn²⁺ ions but not Ag⁺, demonstrating high metal-binding specificity. Partially oxidized Cox17 (two disulfide bonds) binds one Cu⁺ or Zn²⁺; fully oxidized Cox17 (three disulfide bonds) binds no metals.\",\n      \"method\": \"Electrospray ionization mass spectrometry (ESI-MS), fluorescence spectroscopy, DTT competition assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro quantitative metal-binding characterization with multiple spectroscopic methods in a single study\",\n      \"pmids\": [\"15142040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NMR solution structure of oxidized apoCox17 reveals a coiled-coil fold stabilized by two disulfide bonds (Cys26/Cys57 and Cys36/Cys47); isomerization of the Cys26/Cys57 disulfide to Cys24/Cys57 is required prior to Cu(I) binding. A third fully oxidized form cannot bind copper; fully reduced Cox17 forms a molten globule that can bind up to four Cu(I) ions in a polycopper cluster and is oligomeric.\",\n      \"method\": \"NMR solution structure, disulfide bond analysis, Cu(I) binding assays\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure determination combined with biochemical characterization of multiple redox/metal states, replicated across labs\",\n      \"pmids\": [\"15893662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The P174L mutation in human Sco1 severely compromises Cox17-dependent copper transfer to Sco1 in vitro and in a yeast cytoplasmic assay, but retains normal Cu(I) and Cu(II) binding; failure of Cox17-mediated metallation of Sco1 leads to rapid turnover of CoxII and COX assembly defects in patient fibroblasts.\",\n      \"method\": \"In vitro copper transfer assay, yeast cytoplasmic assay, pulse-chase labeling, patient fibroblast analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution, yeast genetic validation, and patient cell biochemistry in one study\",\n      \"pmids\": [\"16520371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NMR solution structure of human Cox17 (Cox17²ˢ⁻ˢ) reveals a coiled-coil-helix-coiled-coil-helix domain stabilized by disulfides Cys25-Cys54 and Cys35-Cys44, with an unstructured N-terminal tail; Cu(I) is coordinated by Cys22 and Cys23 (Cys-Cys motif, first example in copper proteins). Redox measurements support that unstructured fully reduced Cox17 enters the IMS where Mia40-mediated oxidation to Cox17²ˢ⁻ˢ traps it and enables copper binding.\",\n      \"method\": \"NMR solution structure, redox potential measurements, subcellular localization analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with redox characterization; novel Cys-Cys copper coordination motif established\",\n      \"pmids\": [\"18093982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mammalian Cox17 exists in three oxidative states with distinct metal-binding properties: Cox17⁰ˢ⁻ˢ (fully reduced) binds four Cu⁺ cooperatively; Cox17²ˢ⁻ˢ (two disulfides) binds one Cu⁺ or Zn²⁺; Cox17³ˢ⁻ˢ (three disulfides) binds no metals. Redox midpoint potentials: Em1 = -197 mV (Cox17³ˢ⁻ˢ↔Cox17²ˢ⁻ˢ), Em2 = -340 mV (Cox17²ˢ⁻ˢ↔Cox17⁰ˢ⁻ˢ). XAS confirms a Cu₄S₆-type cluster in Cu₄Cox17.\",\n      \"method\": \"Redox potential determination, X-ray absorption spectroscopy (XAS), ESI-MS\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods (XAS, electrochemistry, MS) in a single study\",\n      \"pmids\": [\"17672825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Human Cox17²ˢ⁻ˢ loaded with Cu(I) transfers copper and two electrons simultaneously to oxidized HSco1 (disulfide form), yielding Cu(I)HSco1 and fully oxidized apoHCox17³ˢ⁻ˢ; glutathione can reduce apoHCox17³ˢ⁻ˢ back to Cox17²ˢ⁻ˢ. This coupled copper-electron transfer does not occur with HSco2 due to lack of a specific metal-bridged protein-protein complex.\",\n      \"method\": \"In vitro copper transfer assay with purified proteins, NMR spectroscopy to detect protein-protein complex, redox analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro coupled copper/electron transfer with NMR detection of intermediate complex; mechanistically novel finding\",\n      \"pmids\": [\"18458339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"COX17 siRNA knockdown in HeLa cells reduces cytochrome c oxidase activity and assembly; COX-containing respiratory supercomplexes disappear as an early response, and a novel ~150 kDa complex accumulates containing Cox1 but not Cox2, suggesting Cox17 absence specifically impairs copper delivery to Cox2.\",\n      \"method\": \"siRNA knockdown, blue native gel electrophoresis, cytochrome c oxidase activity assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with defined biochemical phenotype and intermediate complex identification, single lab\",\n      \"pmids\": [\"19393246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Structural analysis of human Cox17 mutants with single disulfide bonds shows the inner disulfide (Cys36-Cys45) stabilizes interhelical hydrophobic interactions and is sufficient to maintain the mature Cox17 structure/dynamics, while the external disulfide (Cys26-Cys55) organizes the copper-binding site region but cannot stabilize interhelical packing.\",\n      \"method\": \"NMR structure determination and backbone mobility analysis of Cox17 disulfide mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural analysis with functional mutants defining individual disulfide roles\",\n      \"pmids\": [\"21816817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cox17 directly interacts with Mic60 of the MICOS complex, modulating MICOS integrity and inner mitochondrial membrane architecture; this interaction is independent of Sco1 but is regulated by copper ions.\",\n      \"method\": \"Co-immunoprecipitation, genetic interaction analysis, MICOS complex integrity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP with functional consequence on MICOS integrity shown, single lab\",\n      \"pmids\": [\"25918166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cox17 facilitates delivery of cisplatin to mitochondria; glutathione significantly modulates platinum binding to Cox17, with cisplatin-GSH adducts transferring >90% platinum to Cox17, while transplatin-GSH adducts are inert to Cox17, and GSH attenuates Cox17 aggregation induced by platination.\",\n      \"method\": \"Kinetic binding assays, platinum transfer assays, protein aggregation assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro reconstitution of platinum transfer, single lab, single study\",\n      \"pmids\": [\"26399480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cisplatin binds to human Cox17²ˢ⁻ˢ primarily at Cys26 or Cys27 (the Cu(I)-binding site), as determined by top-down FT-ICR-MS/MS with electron capture dissociation, demonstrating competitive coordination with cuprous ions.\",\n      \"method\": \"High-resolution FT-ICR tandem mass spectrometry with electron capture dissociation (ECD)\",\n      \"journal\": \"Rapid communications in mass spectrometry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct site identification by top-down MS, single lab, single method\",\n      \"pmids\": [\"27539433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Stable COX17 shRNA knockdown in HEK293 cells causes decreased intramitochondrial copper content, reduced levels of COX subunits (Cox1, Cox4, Cox5a), accumulation of COX subcomplexes, and mitochondrial ultrastructural changes including cristae reduction and mitochondrial swelling, confirming copper chaperone role in human cells.\",\n      \"method\": \"Stable shRNA knockdown, copper quantification, BN-PAGE, electron microscopy, western blot\",\n      \"journal\": \"Folia biologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with multiple biochemical and ultrastructural readouts, single lab\",\n      \"pmids\": [\"31903891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"COX17 is acetylated by the MOF-KANSL lysine acetyltransferase complex; loss of MOF or COX17, or expression of non-acetylatable COX17 mutant, causes mitochondrial fragmentation, reduced cristae density, and impaired complex IV integrity; acetylation-mimetic COX17 rescues complex IV activity even in absence of MOF, establishing activatory role of COX17 acetylation.\",\n      \"method\": \"MOF knockout/knockdown, site-directed mutagenesis (acetylation-mimetic and non-acetylatable mutants), mitochondrial complex IV activity assay, electron microscopy, patient fibroblast complementation\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (KO, mutagenesis, patient cells, rescue), identification of writer (MOF), functional consequence established\",\n      \"pmids\": [\"37813994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Lead (Pb) exposure enhances mitochondrial translocation of COX17 via the AIF/CHCHD4 mitochondrial import pathway, increasing mitochondrial copper concentration and causing mitochondrial damage in microglia; copper-chelating agents or inhibition of COX17 mitochondrial translocation reverses this effect.\",\n      \"method\": \"In vivo APP/PS1 mouse model, in vitro BV-2 cell model, copper quantification, mitochondrial fractionation, pathway inhibition\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro models with mechanistic rescue, single lab\",\n      \"pmids\": [\"38091880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"COX17 knockdown in fibrotic kidney models aggravates mitochondrial copper accumulation and inhibits complex IV activity, while COX17 overexpression discharges excess mitochondrial copper and restores complex IV function, demonstrating a bidirectional role of COX17 in mitochondrial copper homeostasis and complex IV maintenance.\",\n      \"method\": \"UUO mouse model, TGF-β1 in vitro fibrosis model, COX17 knockdown and overexpression, complex activity assays, copper quantification\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro bidirectional manipulation with defined biochemical readouts, single lab\",\n      \"pmids\": [\"37217601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A human cDNA encoding a protein homologous to yeast Cox17p functionally complements a yeast cox17 null mutant for respiratory growth, establishing functional conservation of the copper-delivery mechanism in human cells.\",\n      \"method\": \"Functional complementation of yeast cox17 null mutant with human cDNA expression library\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct functional complementation across species, replicated in subsequent studies\",\n      \"pmids\": [\"9050918\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COX17 is a mitochondrial intermembrane space copper chaperone that, in its partially oxidized form (two disulfide bonds, Cox17²ˢ⁻ˢ), binds one Cu(I) ion via a Cys-Cys motif and directly transfers copper—coupled to electron transfer—to both Sco1 (for the Cu_A site of Cox2) and Cox11 (for the Cu_B site of Cox1) during cytochrome c oxidase assembly; it is imported into the IMS in its unstructured reduced form and trapped there by Mia40-dependent disulfide oxidation, its activity is positively regulated by MOF-mediated acetylation, it interacts with the MICOS component Mic60 to modulate inner membrane architecture in a copper-regulated manner, and it also facilitates cisplatin delivery to mitochondria by binding the drug at its Cu(I)-coordination cysteines.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"COX17 is a mitochondrial intermembrane space (IMS) copper chaperone that delivers copper to the cytochrome c oxidase (complex IV) assembly machinery, a role first established genetically when a cox17 null mutant was shown to be specifically rescued by copper supplementation [#0] and confirmed to be functionally conserved in humans by complementation of the yeast mutant [#23]. The protein is imported into the IMS in an unstructured, fully reduced state and trapped there by Mia40-dependent oxidation to the Cox17\\u00b2\\u02e2\\u207b\\u02e2 form, which acquires a coiled-coil-helix fold stabilized by two disulfide bonds and binds a single Cu(I) ion through a Cys-Cys motif [#11, #9]. Its redox-dependent metal-binding repertoire is graded across oxidation states: fully reduced Cox17 binds up to four Cu(I) ions in a polycopper Cu\\u2084S\\u2086 cluster, the doubly-disulfide form binds one Cu(I), and the fully oxidized form binds none [#12, #8, #9]. A C-terminal amphipathic helix retains Cox17 in the IMS, and tethering it to the inner membrane fully restores function, demonstrating that its activity is confined to this compartment [#4]. The metallated Cox17\\u00b2\\u02e2\\u207b\\u02e2 form directly and specifically transfers Cu(I) to both Sco1 and Cox11 in vitro, feeding the Cu_A and Cu_B sites of complex IV; transfer to Sco1 is mechanistically coupled to a two-electron transfer that oxidizes Cox17 to its disulfide form, and the C57Y mutant selectively loses the Sco1 pathway while retaining transfer to Cox11 [#5, #13]. Disruption of COX17 in human cells reduces intramitochondrial copper, impairs complex IV assembly with accumulation of subassemblies lacking copper-loaded Cox2, and alters mitochondrial cristae ultrastructure [#14, #19]. The chaperone's activity is positively regulated by MOF-KANSL-mediated acetylation [#20], and it interacts with the MICOS component Mic60 to modulate inner-membrane architecture in a copper-regulated manner [#16]. A patient SCO1 P174L mutation that blocks Cox17-mediated metallation of Sco1 establishes the clinical relevance of this transfer step to complex IV deficiency [#10]. Beyond copper handling, Cox17 binds cisplatin at its Cu(I)-coordinating cysteines and facilitates platinum delivery to mitochondria [#18, #17].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that COX17 is dedicated to copper delivery for complex IV assembly rather than general copper metabolism, defining the gene's biological purpose.\",\n      \"evidence\": \"Genetic complementation and copper-supplementation rescue of a yeast cox17 null mutant\",\n      \"pmids\": [\"8662933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not localize the protein or identify the molecular form of copper delivered\", \"Downstream acceptors of copper not yet identified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed the copper-delivery mechanism is conserved to humans, validating yeast as a model for the human chaperone.\",\n      \"evidence\": \"Functional complementation of yeast cox17 null with human cDNA\",\n      \"pmids\": [\"9050918\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not characterize human protein structure or partners\", \"Conservation of mechanism inferred from rescue, not directly demonstrated biochemically\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the chemical nature of copper binding, distinguishing a labile delivery-competent cluster from stable storage proteins.\",\n      \"evidence\": \"EXAFS and UV-vis/emission spectroscopy of the cuprous-thiolate cluster\",\n      \"pmids\": [\"9585572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not assign individual coordinating cysteines\", \"Physiological oxidation state and oligomeric form unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified the Cys-Cys-Xaa-Cys motif as functionally essential and separated the requirement for copper binding from in vivo function, indicating function depends on more than metal coordination alone.\",\n      \"evidence\": \"Site-directed mutagenesis with respiratory growth, COX activity, Cu(I) binding, and import readouts in yeast\",\n      \"pmids\": [\"10970896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why Cys mutants that still bind copper are non-functional was unexplained\", \"Did not define the role of disulfides versus thiols\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linked oligomeric state to function, showing tetramerization correlates with mitochondrial localization and physiological activity.\",\n      \"evidence\": \"XAS, analytical ultracentrifugation, mutagenesis, and subcellular fractionation of yeast Cox17\",\n      \"pmids\": [\"11170391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional necessity of tetramer for copper transfer not directly tested\", \"Relationship between oligomerization and redox state unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved the long-standing question of where Cox17 acts by confining its function to the IMS and mapping a separable membrane-retention helix.\",\n      \"evidence\": \"Inner-membrane tethering fusion with respiratory complementation and domain mapping in yeast\",\n      \"pmids\": [\"14615477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address the reported cytosolic pool's function\", \"Mechanism of IMS retention by the amphipathic helix not detailed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated Cox17 directly and specifically metallates both Sco1 and Cox11, defining the two downstream copper acceptors and revealing genetically separable transfer pathways.\",\n      \"evidence\": \"In vitro Cu(I) transfer with purified proteins, C57Y mutant dissection, and yeast cytoplasmic co-expression\",\n      \"pmids\": [\"15199057\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve why C57Y selectively loses the Sco1 route\", \"Stoichiometry and complex intermediates of transfer not defined here\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed Cox23 upstream of Cox17 in the same assembly pathway, hinting at a multi-step copper relay without a stable Cox17-Cox23 complex.\",\n      \"evidence\": \"Genetic epistasis by high-copy COX17 rescue, fractionation, and exclusion Co-IP in yeast\",\n      \"pmids\": [\"15145942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The biochemical activity of Cox23 and the nature of its handoff to Cox17 unknown\", \"Transient interaction not excluded\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantified the redox-state-dependent metal-binding hierarchy, showing oxidation tunes copper capacity from four ions to one to none.\",\n      \"evidence\": \"ESI-MS, fluorescence, and DTT competition on porcine Cox17\",\n      \"pmids\": [\"15142040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiologically active oxidation state in vivo not pinned down\", \"Functional role of Zn(II) binding unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Provided the first apo-structure showing an intrinsically disordered N-terminus that becomes ordered on Cu(I) binding via a two-coordinate Atx1-like site.\",\n      \"evidence\": \"NMR solution structure and ITC of yeast apo-Cox17\",\n      \"pmids\": [\"15465825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the metallated transfer-competent state not solved here\", \"Disulfide topology not yet integrated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the disulfide-folded oxidized structure and a required disulfide isomerization step preceding copper binding, framing oxidation as the maturation switch.\",\n      \"evidence\": \"NMR structures of oxidized apoCox17 and biochemical analysis of redox/metal states\",\n      \"pmids\": [\"15893662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The catalyst of the required disulfide isomerization not identified here\", \"Coupling of isomerization to import not yet shown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected Cox17-dependent Sco1 metallation to human disease by showing a patient SCO1 mutation blocks copper transfer without disrupting Sco1 metal binding.\",\n      \"evidence\": \"In vitro and yeast transfer assays, pulse-chase, and patient fibroblast analysis of SCO1 P174L\",\n      \"pmids\": [\"16520371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The structural basis of the transfer-specific defect not resolved\", \"Whether COX17 mutations themselves cause disease not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established the human Cox17\\u00b2\\u02e2\\u207b\\u02e2 structure with the novel Cys-Cys copper coordination motif and linked Mia40-mediated oxidation to IMS trapping and copper-binding competence.\",\n      \"evidence\": \"NMR solution structure, redox potential measurement, and localization of human Cox17\",\n      \"pmids\": [\"18093982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct demonstration of Mia40 oxidation of Cox17 in vivo not shown here\", \"Kinetics of import-coupled folding undefined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Measured redox midpoint potentials defining the energetics that govern interconversion among the three oxidation states and their distinct copper capacities.\",\n      \"evidence\": \"Electrochemical redox titration, XAS, and ESI-MS on mammalian Cox17\",\n      \"pmids\": [\"17672825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo redox poise of the IMS Cox17 pool not determined\", \"Coupling of potentials to physiological redox partners not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Revealed that copper transfer to Sco1 is mechanistically coupled to a two-electron transfer through a metal-bridged complex, explaining the Sco1/Sco2 transfer specificity.\",\n      \"evidence\": \"In vitro coupled copper/electron transfer with NMR detection of the intermediate complex and redox analysis\",\n      \"pmids\": [\"18458339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of the transient Cox17-Sco1 complex not resolved\", \"Source of reducing equivalents (GSH) regulation in vivo unquantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated in human cells that loss of Cox17 specifically blocks copper delivery to Cox2, with loss of supercomplexes and accumulation of a Cox1-containing, Cox2-deficient intermediate.\",\n      \"evidence\": \"siRNA knockdown, BN-PAGE, and COX activity assay in HeLa cells\",\n      \"pmids\": [\"19393246\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct linkage of the 150 kDa intermediate to copper status not biochemically proven\", \"Effects on Cox1 Cu_B metallation not separately assessed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Dissected the distinct structural roles of the two disulfides, separating interhelical stabilization from copper-site organization.\",\n      \"evidence\": \"NMR structure and backbone dynamics of single-disulfide human Cox17 mutants\",\n      \"pmids\": [\"21816817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional copper-transfer competence of single-disulfide forms not tested\", \"In vivo abundance of these intermediate forms unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended Cox17 function beyond copper relay by showing a copper-regulated interaction with Mic60 that modulates MICOS integrity and inner-membrane architecture.\",\n      \"evidence\": \"Co-IP, genetic interaction, and MICOS integrity assays\",\n      \"pmids\": [\"25918166\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without structural mapping of the interface\", \"Whether this is a moonlighting role or coupled to copper delivery unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified Cox17 as a facilitator of cisplatin delivery to mitochondria, with glutathione gating platinum loading.\",\n      \"evidence\": \"Kinetic binding, platinum transfer, and aggregation assays in vitro\",\n      \"pmids\": [\"26399480\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance to cisplatin pharmacology not established\", \"Single in vitro study\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Localized cisplatin binding to the Cu(I)-coordinating cysteines, defining competitive metal/drug coordination at the chaperone's active site.\",\n      \"evidence\": \"Top-down FT-ICR MS/MS with electron capture dissociation\",\n      \"pmids\": [\"27539433\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-method site assignment without orthogonal confirmation\", \"Functional consequence for copper chaperone activity not measured\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Confirmed the human copper-chaperone role with a clean phenotype linking COX17 loss to reduced mitochondrial copper, COX subassembly accumulation, and cristae defects.\",\n      \"evidence\": \"Stable shRNA knockdown, copper quantification, BN-PAGE, EM, and western blot in HEK293 cells\",\n      \"pmids\": [\"31903891\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Did not distinguish direct copper-delivery defect from secondary mitochondrial damage\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified MOF-KANSL acetylation as a positive regulatory input controlling Cox17 activity and complex IV integrity.\",\n      \"evidence\": \"MOF KO/KD, acetylation-mimetic and non-acetylatable mutants, complex IV assays, EM, and patient fibroblast rescue\",\n      \"pmids\": [\"37813994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetylated residue's effect on copper binding/transfer mechanism not resolved\", \"Deacetylase and physiological signals tuning acetylation unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed inducible mitochondrial import of COX17 via the AIF/CHCHD4 pathway as a route by which lead exposure drives mitochondrial copper overload and damage.\",\n      \"evidence\": \"APP/PS1 mouse and BV-2 cell models, copper quantification, fractionation, and pathway inhibition\",\n      \"pmids\": [\"38091880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether enhanced import reflects increased flux through normal machinery or a stress-specific route unclear\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed COX17 acts bidirectionally in mitochondrial copper homeostasis, both maintaining complex IV and discharging excess copper.\",\n      \"evidence\": \"UUO and TGF-\\u03b21 fibrosis models with COX17 knockdown and overexpression, activity assays, and copper quantification\",\n      \"pmids\": [\"37217601\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of copper efflux/discharge function not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple Cox17 functions\\u2014copper relay, MICOS modulation, acetylation control, and copper efflux\\u2014are integrated and prioritized in vivo, and whether COX17 variants directly cause human complex IV disease, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the transfer-competent Cox17-Sco1/Cox11 complexes in cells\", \"No reported COX17 disease mutation despite established pathway relevance\", \"Mechanism of copper discharge/efflux unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 5, 13]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [1, 8, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005758\", \"supporting_discovery_ids\": [4, 7, 11]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [4, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 14, 19]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 19, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SCO1\", \"COX11\", \"MIC60\", \"MOF\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}